Vitamediq Life Science Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.50 M
- Company Age 2 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.20 M
About Vitamediq Life Science
Vitamediq Life Science Private Limited (VLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 April 2022 (Two years and ten months 15 days old ). Its registered office is in Surat, Gujarat, India.
The Corporate was formerly known as Vitamediq Manufacturers Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹8.20 M.
Seema Khetan and Raju Baravaliya serve as directors at the Company.
Company Details
- Location
Surat, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24230GJ2022PTC130927
- Company No.
130927
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Apr 2022
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Vitamediq Life Science?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Seema Khetan  | Director | 11-Apr-2022 | Current |
| Raju Baravaliya | Director | 11-Apr-2022 | Current |
Financial Performance of Vitamediq Life Science.
Enhance accessibility to Vitamediq Life Science's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Vitamediq Life Science?
Unlock access to Vitamediq Life Science's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹8.20 M
₹0
Charges Breakdown by Lending Institutions
- Tjsb Sahakari Bank Limited : 0.82 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Oct 2022 | Tjsb Sahakari Bank Limited | ₹8.20 M | Open |
How Many Employees Work at Vitamediq Life Science?
Vitamediq Life Science has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vitamediq Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vitamediq Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
